Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany

MS Treatments

Jahr

Publikationsjahr
2022

Autoren

Autorenliste der Publikation
Koeditz D, Frensch J, Bierbaum M, Ness NH, Ettle B, Vudumula U, Gudala K, Adlard N, Tiwari S, Ziemssen T.

Verlag

Publisher-Information
Mult Scler J Exp Transl Clin. 2022 Mar 29;8(1):20552173221085741.

Link

Zur Publikation (externer Server)
https://doi.org/10.1177/20552173221085741

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
Treatments2022